One of the most surprising findings in aging science this year: your brain may depend on trace amounts of lithium to stay resilient as you age—and a deficiency may quietly accelerate neurodegeneration.
A new Nature paper reveals that lithium levels are significantly reduced in the brains of people with mild cognitive impairment (MCI) and Alzheimer’s disease (AD), even when blood levels appear normal. The culprit? Amyloid plaques sequester lithium, depleting its availability just when the brain needs it most.
In mouse models, dietary lithium deficiency triggered hallmark features of Alzheimer’s and brain aging:
Elevated amyloid-β and tau
Synapse and myelin loss
Memory decline
Microglial inflammation
Transcriptomic aging across neurons and glia
🌟 The most promising intervention? Lithium orotate (LiO)—a low-dose, brain-accessible form of lithium that avoids amyloid binding. In aging and AD-model mice, LiO:
Prevented and reversed pathology
Restored cognition
Reduced neuroinflammation
Showed no toxicity with long-term use
💧Importantly, this aligns with earlier findings in humans:
A Danish population study showed that regions with higher lithium in drinking water had significantly lower rates of dementia. These new results offer a potential explanation—maintaining lithium homeostasis may protect the aging brain.
🔁 This research reframes lithium not just as a psychiatric drug, but as a trace element essential for brain longevity. Deficiency may act as a tipping point—while timely, physiological lithium support could delay or even prevent cognitive decline.
For those of us working to delay age-related chronic diseases, this could be a game-changer.
📖 Study: “Lithium Deficiency and the Onset of Alzheimer’s Disease” – Nature, August 2025